Is there a role for botanical medicines in the twenty‐first century?

China and the WHO's promotion of herbal and traditional medicines, most of which were not tested for safety and efficacy, have raised public health concerns.

• Publication year

  2020

• Venue

  EMBO Reports

• Publication date

  2020-10-27

• Fields of study

  Political Science, Medicine, Environmental Science

• Identifiers
  DOI 10.15252/embr.202051376PMID 33107689PMCID PMC7645263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• WHO traditional medicine strategy: 2014–2023

  2022cited by this paper
• Defending science from what?

  2021cited by this paper
• Is there a role for botanical medicines in the twenty‐first century?

  2020cited by this paper
• WHO's Next - The United States and the World Health Organization.

  2020cited by this paper
• Antimalarial Drugs in Ghana: A Case Study on Personal Preferences

  2020cited by this paper
• The World Health Organization’s decision about traditional Chinese medicine could backfire

  2019cited by this paper
• Why Chinese medicine is heading for clinics around the world

  2018cited by this paper
• Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia

  2017cited by this paper
• Dietary supplements: What's in a name? What's in the bottle?

  2016cited by this paper
• Global hazards of herbal remedies: lessons from Aristolochia

  2016cited by this paper
• The Supplement Paradox: Negligible Benefits, Robust Consumption.

  2016cited by this paper
• Safety Surveillance of Traditional Chinese Medicine: Current and Future

  2015cited by this paper
• Review article: herbal hepatotoxicity – an update on traditional Chinese medicine preparations

  2014cited by this paper
• Deep Sequencing of Plant and Animal DNA Contained within Traditional Chinese Medicines Reveals Legality Issues and Health Safety Concerns

  2012cited by this paper
• Aristolochic acids.

  2011cited by this paper
• Acute kidney injury associated with the use of traditional medicines

  2008cited by this paper
• Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

  2000cited by this paper
• Health Fraud: A Hardy Perennial

  1997cited by this paper
• Qinghaosu (artemisinin): an antimalarial drug from China

  1985cited by this paper
• Qinghaosu (artemisinin): an antimalarial drug from China.

  1985cited by this paper
• Antimalarial drugs.

  1947cited by this paper
• UROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI )

  year unknowncited by this paper

• Immunomodulatory effects of hexanoic extract of Narcissus tazetta flowers after subacute exposure to BALB/c mice through a phased approach immunotoxicity assessment.

  2025cites this paper
• The Effect of Chinese Medicinal Formulas on Biomarkers of Oxidative Stress in STZ-Induced Diabetic Kidney Disease Rats: A Meta-Analysis and Systematic Review

  2022cites this paper
• Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy

  2021cites this paper
• Is there a role for botanical medicines in the twenty‐first century?

  2020cites this paper